Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dalton Trans ; (26): 5132-6, 2009 Jul 14.
Artigo em Inglês | MEDLINE | ID: mdl-19562173

RESUMO

A new dirhenium(III) complex cis-[Re2(GABA)2Cl5(H2O)]Cl.2H2O with zwitterionic gamma-aminobutyrate ligands was prepared and characterized by spectral methods and crystallography. The structure of the compound is comprised of dinuclear complex cations (Re-Re 2.2437(3) A) involving cis-oriented double carboxylate bridges, four equatorial chloride ions and two weakly bonded aqua and chloride ligands in the axial positions at two rhenium centers (Re-O 2.363(3), Re-Cl 2.6735(12) A). Antitumor properties of the complex were studied in the model of tumor growth with the use of Wistar rats inoculated by tumor carcinoma Guerink cells. The introduction of the compound in dosage according to the scheme of antioxidant therapy, inhibited the tumor growth by ca. 60% and led to stabilization of red blood cells in the tumor-bearing organisms. The combined introduction of the compound and cisplatin had a significant impact on the tumor growth and the disappearance of the tumors in most of the animals.


Assuntos
Antineoplásicos/síntese química , Cisplatino/uso terapêutico , Compostos Organometálicos/síntese química , Rênio/química , Ácido gama-Aminobutírico/química , Animais , Antineoplásicos/química , Antineoplásicos/uso terapêutico , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Linhagem Celular Tumoral , Cristalografia por Raios X , Sinergismo Farmacológico , Ligantes , Lipossomos , Modelos Moleculares , Estrutura Molecular , Transplante de Neoplasias , Neoplasias Experimentais/tratamento farmacológico , Compostos Organometálicos/química , Compostos Organometálicos/uso terapêutico , Ratos , Ratos Wistar , Ensaios Antitumorais Modelo de Xenoenxerto
2.
Chem Biodivers ; 5(8): 1660-1667, 2008 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-18729101

RESUMO

Liposomal formulations of dinuclear cluster rhenium (Re) compounds were used in biochemical trials. Interaction of liposomal forms of some Re compounds with red blood cells in experiments in vitro showed strong cell-stabilizing properties. In the models of tumor growth and hemolytic anemia in vivo, liposomal forms had better therapeutic effects in comparison with their solutions. The process of formation of liposomes of cluster Re compounds with different organic ligands was investigated by the method of electronic absorption spectra and mechanism of their interactions with lipids is proposed. Encapsulation of cluster Re compounds to lipid coating may have activation significance for the quadruple Re-Re bond.


Assuntos
Anemia Hemolítica Autoimune/tratamento farmacológico , Antineoplásicos/química , Antineoplásicos/farmacologia , Eritrócitos/efeitos dos fármacos , Compostos Organometálicos/química , Compostos Organometálicos/farmacologia , Rênio/química , Anemia Hemolítica Autoimune/induzido quimicamente , Animais , Antineoplásicos/uso terapêutico , Desenho de Fármacos , Eritrócitos/química , Humanos , Ligantes , Lipossomos , Neoplasias Experimentais/induzido quimicamente , Neoplasias Experimentais/tratamento farmacológico , Compostos Organometálicos/uso terapêutico , Coelhos , Ratos , Ratos Wistar , Espectrofotometria Ultravioleta , Relação Estrutura-Atividade
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...